Functional Analysis of an Intronic FBN1 Pathogenic Gene Variant in a Family With Marfan Syndrome

Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder that canonically affects the ocular, skeletal, and cardiovascular system, in which aortic tear and rupture is the leading cause of death for MFS patients. Genetically, MFS is primarily associated with fibrillin-1 (FBN1) pathog...

Full description

Bibliographic Details
Main Authors: Kui Hu, Yun Wan, Fu-Tsuen Lee, Jinmiao Chen, Hao Wang, Haonan Qu, Tao Chen, Wang Lu, Zhenwei Jiang, Lufang Gao, Xiaojuan Ji, Liqun Sun, Daokang Xiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.857095/full
_version_ 1818523978260545536
author Kui Hu
Yun Wan
Fu-Tsuen Lee
Fu-Tsuen Lee
Jinmiao Chen
Hao Wang
Haonan Qu
Tao Chen
Wang Lu
Zhenwei Jiang
Lufang Gao
Xiaojuan Ji
Liqun Sun
Daokang Xiang
author_facet Kui Hu
Yun Wan
Fu-Tsuen Lee
Fu-Tsuen Lee
Jinmiao Chen
Hao Wang
Haonan Qu
Tao Chen
Wang Lu
Zhenwei Jiang
Lufang Gao
Xiaojuan Ji
Liqun Sun
Daokang Xiang
author_sort Kui Hu
collection DOAJ
description Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder that canonically affects the ocular, skeletal, and cardiovascular system, in which aortic tear and rupture is the leading cause of death for MFS patients. Genetically, MFS is primarily associated with fibrillin-1 (FBN1) pathogenic variants. However, the disease-causing variant in approximately 10% of patients cannot be identified, partly due to some cryptic mutations that may be missed using routine exonic sequencing, such as non-coding intronic variants that affects the RNA splicing process. We present a 32-year female with typical MFS systemic presentation that reached to a clinical diagnosis according to the revised Ghent nosology. We performed whole-exome sequencing (WES) but the report failed to identify known causal variants when analyzing the exonic sequence. However, further investigation on the exon/intron boundaries of the WES report revealed a candidate intronic variant of the fibrillin 1 (FBN1) gene (c.248-3 C>G) that predicted to affect the RNA splicing process. We conducted minigene splicing analyses and demonstrated that the c.248-3 C>G variant abolished the canonical splicing site of intron 3, leading to activation of two cryptic splicing sites and causing insertion (c.248-1_248-2insAG and c.248-1_248-282ins). Our study not only characterizes an intronic variant to the mutational spectrum of the FBN1 gene in MFS and its aberrant effect on splicing, but highlights the importance to not neglect the exon/intron boundaries when reporting and assessing WES results. We point out the need of conducting functional analysis to verify the pathogenicity of intronic mutation, and the opportunity to re-consider the standard diagnostic approaches in cases of clinically diagnosed MFS with normal or variant of unknown significance genetic results.
first_indexed 2024-12-11T05:51:23Z
format Article
id doaj.art-52a895243a0140dc9489db42c77069a5
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-12-11T05:51:23Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-52a895243a0140dc9489db42c77069a52022-12-22T01:18:49ZengFrontiers Media S.A.Frontiers in Genetics1664-80212022-04-011310.3389/fgene.2022.857095857095Functional Analysis of an Intronic FBN1 Pathogenic Gene Variant in a Family With Marfan SyndromeKui Hu0Yun Wan1Fu-Tsuen Lee2Fu-Tsuen Lee3Jinmiao Chen4Hao Wang5Haonan Qu6Tao Chen7Wang Lu8Zhenwei Jiang9Lufang Gao10Xiaojuan Ji11Liqun Sun12Daokang Xiang13Department of Cardiovascular Surgery, Guizhou Provincial People’s Hospital, Guiyang, ChinaDepartment of Endocrinology, Guizhou Provincial People’s Hospital, Guiyang, ChinaDepartment of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, CanadaDivision of Cardiology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, CanadaDepartment of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, ChinaInstitute of Precision Medicine, The Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Thoracic and Cardiovascular Surgery, The Third People’s Hospital of Mianyang City, Mianyang, ChinaDepartment of Cardiovascular Surgery, Guizhou Provincial People’s Hospital, Guiyang, ChinaDepartment of Cardiovascular Surgery, Guizhou Provincial People’s Hospital, Guiyang, ChinaDepartment of Cardiovascular Surgery, Guizhou Provincial People’s Hospital, Guiyang, ChinaDepartment of Cardiovascular Surgery, Guizhou Provincial People’s Hospital, Guiyang, ChinaDepartment of Ultrasound, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, ChinaDivision of Cardiology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, CanadaDepartment of Cardiovascular Surgery, Guizhou Provincial People’s Hospital, Guiyang, ChinaMarfan syndrome (MFS) is an autosomal dominant connective tissue disorder that canonically affects the ocular, skeletal, and cardiovascular system, in which aortic tear and rupture is the leading cause of death for MFS patients. Genetically, MFS is primarily associated with fibrillin-1 (FBN1) pathogenic variants. However, the disease-causing variant in approximately 10% of patients cannot be identified, partly due to some cryptic mutations that may be missed using routine exonic sequencing, such as non-coding intronic variants that affects the RNA splicing process. We present a 32-year female with typical MFS systemic presentation that reached to a clinical diagnosis according to the revised Ghent nosology. We performed whole-exome sequencing (WES) but the report failed to identify known causal variants when analyzing the exonic sequence. However, further investigation on the exon/intron boundaries of the WES report revealed a candidate intronic variant of the fibrillin 1 (FBN1) gene (c.248-3 C>G) that predicted to affect the RNA splicing process. We conducted minigene splicing analyses and demonstrated that the c.248-3 C>G variant abolished the canonical splicing site of intron 3, leading to activation of two cryptic splicing sites and causing insertion (c.248-1_248-2insAG and c.248-1_248-282ins). Our study not only characterizes an intronic variant to the mutational spectrum of the FBN1 gene in MFS and its aberrant effect on splicing, but highlights the importance to not neglect the exon/intron boundaries when reporting and assessing WES results. We point out the need of conducting functional analysis to verify the pathogenicity of intronic mutation, and the opportunity to re-consider the standard diagnostic approaches in cases of clinically diagnosed MFS with normal or variant of unknown significance genetic results.https://www.frontiersin.org/articles/10.3389/fgene.2022.857095/fullMarfan syndromeintronic variantfibrillin 1RNA splicinggenetic analysis
spellingShingle Kui Hu
Yun Wan
Fu-Tsuen Lee
Fu-Tsuen Lee
Jinmiao Chen
Hao Wang
Haonan Qu
Tao Chen
Wang Lu
Zhenwei Jiang
Lufang Gao
Xiaojuan Ji
Liqun Sun
Daokang Xiang
Functional Analysis of an Intronic FBN1 Pathogenic Gene Variant in a Family With Marfan Syndrome
Frontiers in Genetics
Marfan syndrome
intronic variant
fibrillin 1
RNA splicing
genetic analysis
title Functional Analysis of an Intronic FBN1 Pathogenic Gene Variant in a Family With Marfan Syndrome
title_full Functional Analysis of an Intronic FBN1 Pathogenic Gene Variant in a Family With Marfan Syndrome
title_fullStr Functional Analysis of an Intronic FBN1 Pathogenic Gene Variant in a Family With Marfan Syndrome
title_full_unstemmed Functional Analysis of an Intronic FBN1 Pathogenic Gene Variant in a Family With Marfan Syndrome
title_short Functional Analysis of an Intronic FBN1 Pathogenic Gene Variant in a Family With Marfan Syndrome
title_sort functional analysis of an intronic fbn1 pathogenic gene variant in a family with marfan syndrome
topic Marfan syndrome
intronic variant
fibrillin 1
RNA splicing
genetic analysis
url https://www.frontiersin.org/articles/10.3389/fgene.2022.857095/full
work_keys_str_mv AT kuihu functionalanalysisofanintronicfbn1pathogenicgenevariantinafamilywithmarfansyndrome
AT yunwan functionalanalysisofanintronicfbn1pathogenicgenevariantinafamilywithmarfansyndrome
AT futsuenlee functionalanalysisofanintronicfbn1pathogenicgenevariantinafamilywithmarfansyndrome
AT futsuenlee functionalanalysisofanintronicfbn1pathogenicgenevariantinafamilywithmarfansyndrome
AT jinmiaochen functionalanalysisofanintronicfbn1pathogenicgenevariantinafamilywithmarfansyndrome
AT haowang functionalanalysisofanintronicfbn1pathogenicgenevariantinafamilywithmarfansyndrome
AT haonanqu functionalanalysisofanintronicfbn1pathogenicgenevariantinafamilywithmarfansyndrome
AT taochen functionalanalysisofanintronicfbn1pathogenicgenevariantinafamilywithmarfansyndrome
AT wanglu functionalanalysisofanintronicfbn1pathogenicgenevariantinafamilywithmarfansyndrome
AT zhenweijiang functionalanalysisofanintronicfbn1pathogenicgenevariantinafamilywithmarfansyndrome
AT lufanggao functionalanalysisofanintronicfbn1pathogenicgenevariantinafamilywithmarfansyndrome
AT xiaojuanji functionalanalysisofanintronicfbn1pathogenicgenevariantinafamilywithmarfansyndrome
AT liqunsun functionalanalysisofanintronicfbn1pathogenicgenevariantinafamilywithmarfansyndrome
AT daokangxiang functionalanalysisofanintronicfbn1pathogenicgenevariantinafamilywithmarfansyndrome